News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Zogenix, Inc., Astellas Pharma Inc. Enter Co-promotion Agreement
August 3, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Zogenix and Astellas enter exclusive co-promotion agreement in the US for newly approved Sumavel Dosepro.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Astellas Pharma US, Inc.
MORE ON THIS TOPIC
Insights
Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026
January 29, 2026
·
3 min read
·
Jennifer Smith-Parker
IPO
Eikon, Veradermics, Announce IPO Targets as Cautious Optimism Propels Biotech Market
January 29, 2026
·
3 min read
·
Tristan Manalac
China
AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma
January 29, 2026
·
1 min read
·
Tristan Manalac
Vaccines
Sanofi Suffers Another Sales Dip for ‘Gift to Public Health’ Vaccines
January 29, 2026
·
2 min read
·
Tristan Manalac
